SCHEMBL2934126

SCHEMBL2934126

O=C(c1ccc(Cl)cc1)N1CCC2(CC1)N[C@H](Cc1ccccc1)C(=O)N2Cc1ccc(F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 1/20 0.46
RIPK1 Q13546 1/20 0.43
MGLL Q99685 1/20 0.43
HSD11B1 P28845 1/20 0.43
CCR8 P51685 2/20 0.42
KCNH2 Q12809 2/20 0.42
HSP90AA1 P07900 1/20 0.42
LMNA P02545 2/20 0.42
ALDH1A1 P00352 1/20 0.42
CHRM2 P08172 1/20 0.41
CHRM3 P20309 1/20 0.41
GPR183 P32249 2/20 0.41
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
MAPK10 P53779 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2937011 1.00 CXCR3 (0.46) CXCR3RIPK1MGLLHSD11B1CCR8
SCHEMBL1800862 1.00 CXCR3 (0.46) CXCR3RIPK1MGLLHSD11B1CCR8
Hydrochloric Acid SCHEMBL1801174 0.99 CXCR3 (0.45) CXCR3RIPK1MGLLHSD11B1CCR8
SCHEMBL1799019 0.95 RIPK1 (0.47) RIPK1HSD11B1LMNACHRM2CHRM3
Hydrochloric Acid SCHEMBL1799641 0.94 RIPK1 (0.46) RIPK1HSD11B1LMNACHRM2CHRM3
SCHEMBL2937853 0.94 RIPK1 (0.47) CXCR3RIPK1MGLLCCR8KCNH2
SCHEMBL1801302 0.94 RIPK1 (0.47) CXCR3RIPK1MGLLCCR8KCNH2
SCHEMBL4000263 0.94 RIPK1 (0.47) CXCR3RIPK1MGLLCCR8KCNH2
Hydrochloric Acid SCHEMBL1800383 0.93 RIPK1 (0.47) CXCR3RIPK1MGLLCCR8KCNH2
SCHEMBL2933989 0.89 CYP2D6 (0.54) CXCR3MGLLCCR8KCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730147-B1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2010-02-03 EP claimed
EP-1730147-B1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2010-02-03 EP disclosed
WO-2005095402-A9 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2009-06-11 WO disclosed
EP-1730147-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2006-12-13 EP disclosed
WO-2005095402-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2005-10-13 WO disclosed